Stem Cell Sciences to lead EU-funded drug discovery
Sydney, Sep 26, 2007 (RWE via COMTEX) -- STCSF | charts | news | PowerRating -- (RWE Aust Business News) Stem Cell Sciences plc (ASX:STC) will lead an EU-funded, multinational novel drug screening collaboration using stem cells.
The project, named NEUROscreen, will use Stem Cell Sciences' proprietary neural stem (NS) cell technology and has received a contribution from the EU's 6th Framework Program for Research and Technical Development (FP6).
The EU's contribution to the NEUROscreen project is worth 2.4 million euro over three years, of which approximately 420,000 euro will flow directly to SCS over the three year period.
Stem Cell Sciences to lead EU-funded drug discovery
(tradingmarkets.com)
The project, named NEUROscreen, will use Stem Cell Sciences' proprietary neural stem (NS) cell technology and has received a contribution from the EU's 6th Framework Program for Research and Technical Development (FP6).
The EU's contribution to the NEUROscreen project is worth 2.4 million euro over three years, of which approximately 420,000 euro will flow directly to SCS over the three year period.
Stem Cell Sciences to lead EU-funded drug discovery
(tradingmarkets.com)
Categories
Research and Development0 TrackBacks
Listed below are links to blogs that reference this entry: Stem Cell Sciences to lead EU-funded drug discovery.
TrackBack URL for this entry: http://stemconnect.com/cgi-bin/mt/mt-t.cgi/199
Leave a comment